(Q34385471)

1 August 2017

1 reference

title

Recognition and management of scleroderma in children (English)

1 reference

1 August 2017

Foeldvari I

1

1 reference

1 August 2017

Wulffraat N

series ordinal

2

1 reference

1 August 2017

publication date

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

3

1 reference

1 August 2017

issue

8

1 reference

1 August 2017

page(s)

575-583

1 reference

Autoantibodies against calpastatin in sera from patients with systemic sclerosis

1 August 2017

cites work

1 reference

12 December 2020

Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis

1 reference

12 December 2020

Antinuclear antibodies in children with localized scleroderma

1 reference

12 December 2020

Stimulation of von Willebrand factor antigen release by immunoglobulin from thrombosis prone patients with systemic lupus erythematosus and the anti-phospholipid syndrome

1 reference

12 December 2020

An epidemiological study of scleroderma in the West Midlands

1 reference

12 December 2020

Systemic scleroderma, A clinical study of 727 cases

1 reference

12 December 2020

Gastrointestinal hemorrhage in patients with systemic sclerosis and CREST syndrome

1 reference

12 December 2020

Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial

1 reference

12 December 2020

Cyclosporine in systemic sclerosis. Results of a forty-eight-week open safety study in ten patients

1 reference

12 December 2020

Systemic sclerosis: using high-resolution CT to detect lung disease in children

1 reference

12 December 2020

Interstitial lung disease in systemic sclerosis: comparison of BALF lymphocyte phenotype and DLCO impairment

1 reference

12 December 2020

Detection of early asymptomatic esophageal dysfunction in systemic sclerosis using a new scintigraphic grading method

1 reference

12 December 2020

Gastrointestinal manifestations of scleroderma

1 reference

12 December 2020

Raynaud's phenomenon: a proposal for classification

1 reference

12 December 2020

A disease severity scale for systemic sclerosis: development and testing

1 reference

12 December 2020

Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey

1 reference

12 December 2020

Localized scleroderma in childhood: a report of 30 cases

1 reference

12 December 2020

Prognosis and management of scleroderma and scleroderma-like disorders in children

1 reference

12 December 2020

Scleroderma in childhood

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

12 December 2020

Methotrexate and corticosteroid therapy for pediatric localized scleroderma

1 reference

12 December 2020

Childhood-onset scleroderma: is it different from adult-onset disease

1 reference

12 December 2020

Atypical juvenile generalized scleroderma presenting as polyarthritis and failure to thrive

1 reference

12 December 2020

Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy

1 reference

12 December 2020

Scleroderma and related conditions

1 reference

12 December 2020

Dietary advice in systemic sclerosis: the dangers of a high fibre diet

1 reference

12 December 2020

Scleroderma-like disorders

1 reference

12 December 2020

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

1 reference

12 December 2020

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial

1 reference

12 December 2020

Histopathologic differentiation between localized and systemic scleroderma

1 reference

12 December 2020

Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis

1 reference

12 December 2020

Raynaud syndrome in childhood

1 reference

12 December 2020

International Conference on Systemic Sclerosis.

1 reference

12 December 2020

Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

1 reference

12 December 2020

Preventive effect of an oral prostacyclin analog, beraprost sodium, on digital necrosis in systemic sclerosis. French Microcirculation Society Multicenter Group for the Study of Vascular Acrosyndromes

1 reference

12 December 2020

Comparison of high frequency (20 MHz) ultrasound and palpation for the assessment of skin involvement in systemic sclerosis (scleroderma).

1 reference

12 December 2020

Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit

1 reference

12 December 2020

Systemic sclerosis-associated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin)

1 reference

12 December 2020

Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis

1 reference

12 December 2020

Antinuclear antibodies in localized scleroderma

1 reference

12 December 2020

Topical tocoretinate improved hypertrophic scar, skin sclerosis in systemic sclerosis and morphea

1 reference

12 December 2020

Measurement of functional status, self-assessment, and psychological well-being in scleroderma

1 reference

12 December 2020

Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis

1 reference

12 December 2020

Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children

1 reference

12 December 2020

Systemic and localized scleroderma in children.

1 reference

12 December 2020

Localized scleroderma

1 reference

12 December 2020

Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis

1 reference

12 December 2020

The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993

1 reference

12 December 2020

Antihistone antibodies in patients with localized scleroderma

1 reference

12 December 2020

1 reference

12 December 2020

Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation

1 reference

12 December 2020

Localized scleroderma

1 reference

12 December 2020

A study of the frequency of pericardial and pleural effusions in scleroderma.

1 reference

12 December 2020

Localized scleroderma; a clinical study of two hundred thirty-five cases

1 reference

12 December 2020

Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma

1 reference

12 December 2020

Manifestations of scleroderma pulmonary disease

1 reference

12 December 2020

10.2165/00128072-200103080-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1016987592

0 references

1 reference